Abbott Asks For Reconsideration To End Stent FCA Suit
By Bryan Koenig · January 13, 2016, 3:38 PM EST
Abbott Laboratories asked a Texas federal judge Tuesday to rethink her decision forcing the company to face a whistleblower's False Claims Act lawsuit alleging it marketed stents for off-label uses, arguing...
To view the full article, register now.